Review: Host factors affecting oral candidiasis Candida species are responsible for a wide range of systemic as well as superficial opportunistic infections, which are of particular importance among debilitated and immunocompromised patients. Species of the genus Candida comprise part of the oral commensal microflora of healthy individuals, with Candida albicans being the most common pathogen of the genus. A diverse array of host factors has been implicated in the pathogenesis of oral candidiasis. This paper describes the local, systemic and iatrogenic factors affecting oral candidiasis.
Introduction
Candida species are normal oral commensals 1 found in 17-75% of healthy individuals and most debilitated people. 2, 3 The transition of this innocuous commensal to the disease-causing 'parasite' may be associated with the virulence attributes of the microorganism. 1 A diverse array of local and systemic factors has been implicated in the pathogenesis of oral candidiasis. 1 These factors act in concert and the eventual outcome of these disease processes is frequently related to the superimposition of the local factors upon systemic factors or vice versa. Host factors are of critical importance in the development of the disease state and Candida species are strictly opportunistic pathogens that mainly cause disease when the host defences are inadequate. 1 The interactions between Candida and the host are extremely complex, involving host factors, systemic factors and iatrogenic factors.
Local host factors that predispose to oral candidiasis

Mucosal barrier
For Candida species to establish an infective process, the organisms must adhere to a host surface, proliferate and penetrate the first line of the host's defence which is the keratinised or non-keratinised oral mucosa. The proteins present in these mucosal cells may act as antifungals and retard candidal invasion. 4 Changes in the epithelium of the oral mucosa, atrophy, hyperplasia or dysplasia, may affect the efficiency of the mucosal barrier. 1 It is possible for the superficial mucosa to protect the host against Candida because constant desquamation of the mucosa takes place at a rate greater than Candida growth. 1 Organisms can protect themselves from being sloughed off the surface of the mucosa either by the production of secretions and fluids or the movement of food or by attaching in a specific manner. 5 When attachment takes place on solid surfaces, the organisms benefit from the enriched nutrient status that exists at the solid-liquid interfaces. 6 Furthermore, changes in surface protein glycosylation may expose hydrophobic protein structures on the surface of the cell, 7 which affects adherence properties. Changes in the surface of yeast cells may be caused by Candida-host interactions. For example, adherence to human buccal epithelial cells induces the synthesis of new proteins in Candida albicans and the expression of signal proteins. 8 An understanding of adherence mechanisms, the signals they generate and the processes they induce, may therefore lead to specific preventive treatments for individuals predisposed to candidiasis. 9 In vitro studies show that changing environmental conditions can induce morphogenesis of C. albicans 10 and that the cell surface of the hyphal form of C. albicans displays a number of proteins that are either absent or masked in the yeast form. 11, 12 The hyphal form also exhibits increased adherence properties [13] [14] [15] which appear to correlate with increased expression of the α5β1-like fibronectin receptor in cells forming hyphae. 16 
Saliva
A continuous flow of saliva is important in preventing oral colonisation by Candida because it removes the unattached or loosely attached Candida from the oral cavity.
1 Saliva flow rate 9 as well as the quantity and the quality of the saliva 1 affect microbial clearance. Qualitative changes in saliva such as the content of salivary glucose may also influence the oral carriage of Candida.
1 Glucose may be a prime factor in the predisposition of diabetics to candidiasis as shown by in vitro experiments which demonstrated minimal or no growth of Candida species in saliva but when supplemented with glucose, saliva fostered the multiplication of yeasts. [17] [18] [19] Furthermore, the secretory IgA component of saliva aggregates yeasts and assists in clearance, 20, 21 thus inhibiting candidal adhesion to host surfaces. 1 Saliva also contains antifungal factors such as lysozyme, lactoperoxidase, lactoferrin and histidine-rich polypeptides, which may help to keep the oral Candida populations under control. 1 Oral carriage of Candida species and coliforms is significantly higher among patients with burning mouth syndrome and this may be directly or indirectly related to reduced salivary gland function in this group. 22, 23 A similar increase in oral carriage of Candida has also been demonstrated in patients undergoing cytotoxic or irradiation therapy. 24 Coliforms are regarded as transient oral colonisers that are usually found in small numbers among oral commensals. 23 However, in the above situations they constitute an integral component of resident commensals. The coliforms may further promote Candida colonisation of epithelia because the yeasts co-adhere preferentially to coliforms, for example Klebsiella species, than to epithelial surfaces. 25, 26 Therefore, a higher prevalence of yeasts observed in the abovementioned patient groups could be a secondary phenomenon while the primary colonisation of the oral cavity is facilitated by coliforms. 1 Salivary pH is another factor that may influence oral Candida carriage. There is a correlation between high carriage and low salivary pH on the dorsum of the tongue, 27 under maxillary dentures 1 and in the oral cavity. 1, 28 A possible mechanism whereby low pH conditions may promote oral colonisation is the superior ability of yeasts to adhere to epithelia and denture acrylic surfaces at a low pH of approximately 2 to 4.
14,29 Another mechanism may be the aciduric and acidophilic nature of Candida species which allow them to thrive in a low pH milieu. 10 
Phagocytes
Phagocytes provide the second line of defence against invasive Candida infection. 9 In the immunocompetent host, neutrophils, eosinophils and monocytes phagocytose yeast cells whereas the hyphal forms of C. albicans gain access to deeper tissues. 30 During the acute inflammatory responses to Candida infection, neutrophils predominate. Intracellular killing of Candida involves both oxidative and non-oxidative mechanisms. 31 Granulocytes and macrophages require augmentation by cytokines such as interferon-gamma, granulocyte-macrophage colony-stimulating factor, and interleukin-1 and -2, produced by T cells for maximum killing efficiency. 31, 32 A significant factor in the pathogenicity of C. albicans is the ability of surface molecules, such as mannoproteins and complement receptors, to modulate phagocyte responses. 31 The importance of cell-mediated immunity in resistance to Candida infection is illustrated by the severe mucosal candidiasis seen with T cell dysfunction in AIDS patients and in many people with chronic mucocutaneous candidiasis. 10 
Morphogenesis
C. albicans can grow in a number of morphological forms, ranging from yeast to hyphae. 9 Pseudohyphal forms are found. This morphology can also be assumed by several other Candida species as well. 10 There is a belief that the hyphae are the invasive and pathogenic form, while the vegetative yeast is the commensal non-pathogenic form. Evidence for this is, however, equivocal.
10, 33 Sherwood et al. 34 demonstrated that hyphae are capable of contact-sensing or thigmotropism. C. albicans hyphae incubated on perforated filters on agar plates grew through the pores and along the grooves of the filters. This property could facilitate the penetration of some tissues. Some C. albicans strains exhibit switching of colony morphology when nutritionally stressed which is accompanied in some cases by chromosomal translocation. 35 This phenotypic switching may be a genetic mechanism that allows asexual C. albicans to adapt to environmental change. 35 Systemic factors which predispose to oral candidiasis
Immunocompromised individuals
The mechanisms that protect the human host against fungal infection depend upon a combination of factors. In the immunocompromised patient, alterations in phagocytic or lymphocytic cell numbers or function are often the most critical factors predisposing to fungal infection. 36 
Diabetes and oral candidiasis
Although oral candidiasis is prevalent among diabetics, the mechanism which predisposes these individuals to high oral carriage of this organism is not clear. 1 It is accepted that high salivary glucose levels among diabetics favour the growth of yeasts. 17, 37 However, some investigators have not been able to show a relationship between glycaemic control and oral carriage. 38, 39 It seems that defects in Candida-cidal activity of neutrophils, particularly in the presence of glucose may promote oral carriage of Candida among diabetics. 40 Furthermore, Farman and Nutt 41 have found microvascular degeneration in capillaries within the lamina propria with atrophic candidal glossitis in diabetics which might promote carriage and infection.
The adhesion of Candida to buccal epithelial cells obtained from diabetics was significantly higher (p<0.001; 55% increase) than to cells obtained from non-diabetic controls 42 . This implies that there may be intrinsic qualitative changes on the cell surface receptors modulating yeast adhesion in diabetes.
1,42
HIV and oral candidiasis
Oropharyngeal candidiasis is the most common fungal infection among patients infected with HIV. [43] [44] [45] C. albicans strains are the prevailing species causing oral candidiasis among patients with HIV infection [46] [47] [48] and are identical to the commensal organisms found in healthy individuals. 49 Oral candidiasis is one of the earliest indictors of the progression to AIDS. 9 It becomes clinically apparent in the prodromal stages of AIDS 50 with more than 75% of infected patients presenting with candidiasis during the course of the disease. 51 Oesophageal candidiasis among AIDS patients can be extensive. 52 This high frequency of oral Candida carriage 51, 53 and candidiasis among HIV-seropositive and AIDS patients emphasises that a fully-functional immune system is needed to prevent candidiasis.
Leukaemia and lymphoma
Systemic candidiasis associated with malignancies, particularly leukaemias and lymphomas, is well documented. 10 This stems partly from therapeutic measures such as cytotoxic and immunosuppressive drugs and radiotherapy which are essential in the treatment of many malignancies. Concurrent administration of antibiotics is also relevant in this context. 1, 40 These conditions are also associated with characteristic defects of phagocytic or lymphocytic cell numbers or function. 54 The remaining neutrophils have metabolic defects which result in impaired migration and microbicidal function. Furthermore, treatment leads to profound neutrophil depletion and deficient T-and B-cell function, which persist until remission is attained.
Altered nutritional states
Nutritional factors act in concert with a number of co-factors in the pathogenesis of oral candidiasis 55 . Amongst others, iron and vitamin deficiency have been investigated and probably influence the disease process via systemic pathways.
Iron deficiency
Iron deficiency may produce an impairment of iron-dependent enzyme systems, thereby affecting the metabolism and, hence, the kinetics of the rapidly dividing oral epithelial cells. 56 Such alterations may result in the epithelial surface becoming more conducive to the adhesion, growth and invasion of Candida. Iron deficiency may also substantially depress the cell-mediated immune response. 57 Other general effects of iron deficiency may include impaired phagocytosis and inadequate antibody production. 58, 59 The association between oral candidiasis and iron deficiency was first described by Cawson. 60 A high prevalence of candidal infection in iron-deficient patients with angular cheilitis and atrophic glossitis has also been reported. 61 Iron deficiency may result in persistent chronic mucocutaneous candidiasis which is difficult to eradicate while the iron deficiency remains. 62 
Vitamin deficiency
Folate deficiency has been reported to cause degenerative changes in the oral mucosa. 63 The latter possibly contributes to the pathogenesis of oral candidiasis by providing a less hostile surface for candidal colonisation.
Iatrogenic factors that predispose the host to infection
Antibiotic therapy
Antibiotic treatment can cause C. albicans overgrowth in the oral cavity by eliminating competing microorganisms and exposing additional sites suitable for colonisation. 9 Broad-spectrum antibiotic therapy e.g. tetracycline, rather than narrow-spectrum antibiotics, is generally accepted as one of the more common iatrogenic factors which initiate oral candidiasis. 1 
Corticosteroid therapy
Corticosteroids have potent anti-inflammatory and immunosuppresive properties. 1, 36 These drugs can lower host resistance to infection and predispose individuals to systemic and superficial candidiasis. 1 Dennis and Itkin 64 were the first to draw attention to the relationship between steroid inhalers and oral candidiasis. The synthetic steroids, beclomethasone dipropionate, betamethasone valerate, sodium cromoglycate and triamcinolone acetonide, used to treat asthma, are also associated with oral and pharyngeal candidiasis. 65 The mechanisms whereby inhaled or systemic steroids predispose to oral candidiasis have as yet not been fully clarified. Treatment with these drugs leads to a marked reduction in neutrophil migration, resulting in suppression of inflammation, associated with impaired neutrophil phagocytic and microbiocidal function. Furthermore, treatment with corticosteroids leads to a profound, but transient reduction in the number of circulating T and B cells. 66 Although corticosteroids do not abolish lymphokine production by activated T cells, the response of macrophages to these mediators is often reduced or destroyed. Also, patients treated with corticosteroids have a high level of salivary glucose which may promote growth, proliferation and adhesion of Candida. 17 
Cytotoxic therapy and radiotherapy (irradiation)
Opportunistic oral candidiasis is commonly observed in patients who are on cytotoxic treatment and radiotherapy. Candida species are responsible for approximately half the oral infections that occur during anti-leukaemia chemotherapy and almost two-thirds of those among patients given antineoplastic drugs for solid tumours. 67 Irradiation affects both the specific and non-specific elements of host protection against infection. The epithelial barrier of the mouth and gastrointestinal tract will often be damaged, but myelosuppression is often the major factor leading to infectious complications. Irradiation also affects most aspects of T and B cell function, resulting in profound suppression of cell-mediated and humoral immunological reactions. 36 Carriage of oral Candida increases during radiotherapy for oral and laryngeal cancer 68 and cytotoxic therapy for solid tumours of oral and perioral regions. 69 
Cigarette/tobacco smoking
The mechanisms whereby Candida carriage and metabolism may be affected, by cigarette or cigar smoke, are uncertain. Arendorf and Walker 27 proposed that smoking may lead to localised epithelial alterations which facilitate colonisation. An alternative hypothesis is that cigarette smoke contains nutritional factors that C. albicans uses readily. 1 Aromatic hydrocarbons in cigarette smoke may be converted by inducible enzyme systems in Candida species to carcinogen endproducts. This, together with the observation that C. albicans can catalyse the formation of N-nitrosobenzyl-methylamine, may partly explain why Candida-associated leucoplakia has a higher potential for malignant change than other leucoplakias. 1 
Conclusion
No single factor but rather a combination of different factors appears to be responsible for the pathogenicity of C. albicans (Table 1) . Dental professionals should be aware that local host factors not only influence colonisation but also the form of Candida infection that is likely to become established. 
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